Lambertus J. Van Den Heuvel
Leuven, VLG 3000, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Characterizing Properdin-Inhibited C3 Nephritic Factors in Patients with Complement-Mediated Kidney Diseases.
Journal: International journal of molecular sciences
Published: April 30, 2026
Atypical Hemolytic Uremic Syndrome in Children and Adults With the Hot Spot C3 Gene Variant p.Arg161Trp.
Journal: Kidney international reports
Published: December 16, 2025
Model-Informed Precision Dosing of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria.
Journal: Clinical pharmacokinetics
Published: May 22, 2025
IdeZ protease does not prevent convertase stabilization by C3 nephritic factors in C3 glomerulopathy.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: November 27, 2024
Prospective validation of initial eculizumab dosing in adults with atypical hemolytic uremic syndrome.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 16, 2024
Levamisole Modulation of Podocytes' Actin Cytoskeleton in Nephrotic Syndrome.
Journal: Biomedicines
Published: October 15, 2023
Ex Vivo Test of Complement Dysregulation in Atypical Hemolytic Uremic Syndrome Kidney Transplant patients: A Pilot Study.
Journal: Kidney international reports
Published: January 30, 2023
Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic Syndrome.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: October 14, 2022
Challenges in diagnostic testing of nephritic factors.
Journal: Frontiers in immunology
Published: September 04, 2022
Circulating Permeability Factors in Focal Segmental Glomerulosclerosis: In V itro Detection.
Journal: Kidney international reports
Published: July 05, 2022
Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective: Results of the CUREiHUS Study.
Journal: Kidney international reports
Published: July 05, 2022
Plasma exchange or immunoadsorption for recurrent focal segmental glomerulosclerosis: clear differences in vitro.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: May 31, 2022
Last Updated: 09/26/2026